Abstract:Enterotoxigenic Escherichia coli (ETEC) is the major bacterial cause of diarrheal diseases in pigs, particularly at young ages, resulting in significant costs to swine farming. The pathogenicity of ETEC is largely dependent on the presence of fimbriae and the ability to produce toxins. Fimbriae are responsible for their initial adhesion to the intestinal epithelial cells, leading to the onset of infection. In particular, the F4 type (K88) fimbriae are often attributed to neonatal infections and have also been associated with post-weaning diarrheal infections. This disease is traditionally prevented or treated with antibiotics, but their use is being severely restricted due to the emergence of resistant bacteria and their impact on human health. Emerging approaches such as aptamers that target the F4-type fimbriae and block the initial ETEC adhesion are a promising alternative. The aim of this study is to assess the effectiveness of two aptamers, Apt31 and Apt37, in controlling ETEC infection in the G. mellonella in vivo model. Initially, the dissociation constant (KD) of each aptamer against ETEC was established using real-time quantitative PCR methodology. Subsequently, different concentrations of the aptamers were injected into Galleria mellonella to study their toxicity. Afterwards, the anti-ETEC potential of Apt31 and Apt37 was assessed in the larvae model. The determined KD was 81.79 nM (95% CI: 31.21-199.4 nM) and 50.71 nM (95% CI: 26.52-96.15 nM) for the Apt31 and Apt37, respectively, showing no statistical difference. No toxicity was observed in G. mellonella following injection with both aptamers at any concentration. However, the administration of Apt31 together with ETEC-F4+ in G. mellonella resulted in a significant improvement of approximately 30% in both larvae survival and health index compared to ETEC-F4+ alone. These findings suggest that aptamers have promising inhibitory effect against ETEC infections and pave the way for additional in vivo studies.

Construction of Aptamer-Functionalized DNA Hydrogels for Effective Inhibition of Shiga Toxin II Toxicity

Discovery and design of an aptamer that inhibits Shiga toxin type 2 activity by blocking Stx2 B subunit-Gb3 interaction

Site-specific incorporation of photo-cross-linker and bioorthogonal amino acids into enteric bacterial pathogens.

A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo

Application of DNA aptamers to block enterotoxigenic Escherichia coli toxicity in a Galleria mellonella larval model

Engineering an Anti-Stx2 Antibody to Control Severe Infections of EHEC O157:H7

Assembly of a Multivalent Aptamer for Efficient Inhibition of Thermostable Direct Hemolysin Toxicity Induced by Vibrio Parahaemolyticus

Effect of an Eco-Friendly Cuminaldehyde Guanylhydrazone Disinfectant on Shiga Toxin Production and Global Transcription of Escherichia coli

One-Step Construction of Tryptophan-Derived Small Molecule Hydrogels for Antibacterial Materials

Inhibition of the lethality of Shiga-like toxin-1 by functional gold nanoparticles

Selection, Identification, and Binding Mechanism Studies of an Ssdna Aptamer Targeted to Different Stages of E. Coli O157:H7.

Selecting DNA aptamers for endotoxin separation

A Nanocomposite Hydrogel with Potent and Broad-Spectrum Antibacterial Activity

Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group

Gb3-Coated Bovine Milk Exosomes as a Practical Neutralizer for Shiga Toxin

De novo design of a pH-triggered self-assembled β-hairpin nanopeptide with the dual biological functions for antibacterial and entrapment

Selection and Characterization of DNA Aptamers Against Staphylococcus Aureus Enterotoxin C1.

DNA Aptamers That Bind to Alginate Hydrogels

Binding Characteristics Study of DNA based Aptamers for E. coli O157:H7

DNA Nanodevice as a Co-delivery Vehicle of Antisense Oligonucleotide and Silver Ions for Selective Inhibition of Bacteria Growth

Gb3 trisaccharide-bearing exosomes as a novel neutralizer for Shiga toxin type 1